837 related articles for article (PubMed ID: 10217327)
21. Structural and dynamic consequences of increasing repeats in a MUC1 peptide tumor antigen.
Schuman JT; Grinstead JS; Apostolopoulos V; Campbell AP
Biopolymers; 2005 Feb; 77(2):107-20. PubMed ID: 15635690
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antibody recognition of mucin 1 (MUC1)-alpha-conotoxin chimera.
Drakopoulou E; Uray K; Mezö G; Price MR; Vita C; Hudecz F
J Pept Sci; 2000 Apr; 6(4):175-85. PubMed ID: 10809390
[TBL] [Abstract][Full Text] [Related]
23. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody.
Baeckström D; Nilsson O; Price MR; Lindholm L; Hansson GC
Cancer Res; 1993 Feb; 53(4):755-61. PubMed ID: 7679050
[TBL] [Abstract][Full Text] [Related]
24. Structural effects of O-glycosylation on a 15-residue peptide from the mucin (MUC1) core protein.
Kirnarsky L; Prakash O; Vogen SM; Nomoto M; Hollingsworth MA; Sherman S
Biochemistry; 2000 Oct; 39(39):12076-82. PubMed ID: 11009623
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Pepscan analyses for epitope mapping of anti-MUC1 monoclonal antibodies--a comparative study and review of five antibodies.
Petrakou E; Murray A; Rosamund C; Graves L; Price MR
Anticancer Res; 1998; 18(6A):4419-21. PubMed ID: 9891503
[TBL] [Abstract][Full Text] [Related]
26. Sequence-variant repeats of MUC1 show higher conformational flexibility, are less densely O-glycosylated and induce differential B lymphocyte responses.
von Mensdorff-Pouilly S; Kinarsky L; Engelmann K; Baldus SE; Verheijen RH; Hollingsworth MA; Pisarev V; Sherman S; Hanisch FG
Glycobiology; 2005 Aug; 15(8):735-46. PubMed ID: 15814824
[TBL] [Abstract][Full Text] [Related]
27. Effect of solution conformation on antibody recognition of a protein core epitope from gastrointestinal mucin (MUC2).
Uray K; Kajtár J; Vass E; Price MR; Hollósi M; Hudecz F
Arch Biochem Biophys; 1999 Jan; 361(1):65-74. PubMed ID: 9882429
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human tumor antigen MUC1 expressed in insect cells: structure and immunogenicity.
Soares M; Hanisch FG; Finn OJ; Ciborowski P
Protein Expr Purif; 2001 Jun; 22(1):92-100. PubMed ID: 11388805
[TBL] [Abstract][Full Text] [Related]
29. Effect of D-amino acid substitution in a mucin 2 epitope on mucin-specific monoclonal antibody recognition.
Uray K; Kajtár J; Vass E; Price MR; Hollósi M; Hudecz F
Arch Biochem Biophys; 2000 Jun; 378(1):25-32. PubMed ID: 10871040
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and conformational analysis of N-glycopeptides. II. CD, molecular dynamics, and NMR spectroscopic studies on linear N-glycopeptides.
Perczel A; Kollát E; Hollósi M; Fasman GD
Biopolymers; 1993 Apr; 33(4):665-85. PubMed ID: 8467070
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and conformational features of human salivary mucin C-terminal derived peptide epitope carrying Thomsen-Friedenreich antigen: implications for its role in self-association.
Satyanarayana J; Gururaja TL; Narasimhamurthy S; Naganagowda GA; Levine MJ
Biopolymers; 2001 Apr; 58(5):500-10. PubMed ID: 11241221
[TBL] [Abstract][Full Text] [Related]
32. Design of a MUC1-based cancer vaccine.
Hanisch FG
Biochem Soc Trans; 2005 Aug; 33(Pt 4):705-8. PubMed ID: 16042579
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity and conformational properties of an N-linked glycosylated peptide epitope of human T-lymphotropic virus type 1 (HTLV-I).
Conrad SF; Byeon IJ; DiGeorge AM; Lairmore MD; Tsai MD; Kaumaya PT
Biomed Pept Proteins Nucleic Acids; 1995; 1(2):83-92. PubMed ID: 9346859
[TBL] [Abstract][Full Text] [Related]
34. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells.
Medina M; Vélez D; Asenjo JA; Egea G; Real FX; Gil J; Subiza JL
Cancer Res; 1999 Mar; 59(5):1061-70. PubMed ID: 10070964
[TBL] [Abstract][Full Text] [Related]
35. Interaction of the receptor binding domains of Pseudomonas aeruginosa pili strains PAK, PAO, KB7 and P1 to a cross-reactive antibody and receptor analog: implications for synthetic vaccine design.
Campbell AP; Wong WY; Houston M; Schweizer F; Cachia PJ; Irvin RT; Hindsgaul O; Hodges RS; Sykes BD
J Mol Biol; 1997 Mar; 267(2):382-402. PubMed ID: 9096233
[TBL] [Abstract][Full Text] [Related]
36. Sequential proton NMR resonance assignments, circular dichroism, and structural properties of a 50-residue substrate-binding peptide from DNA polymerase I.
Mullen GP; Vaughn JB; Mildvan AS
Arch Biochem Biophys; 1993 Feb; 301(1):174-83. PubMed ID: 8442659
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis of antibody binding to mucin glycopeptides in lung cancer.
Qu J; Yu H; Li F; Zhang C; Trad A; Brooks C; Zhang B; Gong T; Guo Z; Li Y; Ragupathi G; Lou Y; Hwu P; Huang W; Zhou D
Int J Oncol; 2016 Feb; 48(2):587-94. PubMed ID: 26692014
[TBL] [Abstract][Full Text] [Related]
38. Glycosylation of the tandem repeat unit of the MUC2 polypeptide leading to the synthesis of the Tn antigen.
Inoue M; Yamashina I; Nakada H
Biochem Biophys Res Commun; 1998 Apr; 245(1):23-7. PubMed ID: 9535776
[TBL] [Abstract][Full Text] [Related]
39. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.
Sørensen AL; Reis CA; Tarp MA; Mandel U; Ramachandran K; Sankaranarayanan V; Schwientek T; Graham R; Taylor-Papadimitriou J; Hollingsworth MA; Burchell J; Clausen H
Glycobiology; 2006 Feb; 16(2):96-107. PubMed ID: 16207894
[TBL] [Abstract][Full Text] [Related]
40. Binding of tumor antigen mucin (MUC1) derived peptides to the heat shock protein DnaK.
Schreiber J; Stahn R; Schenk JA; Karsten U; Pecher G
Anticancer Res; 2000; 20(5A):3093-8. PubMed ID: 11062727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
